Inovio Pharmaceuticals, Inc. is a biotechnology company focused on pioneering, developing, and commercializing DNA medicines. Its overarching goal is to treat ailments and provide protection against diseases stemming from human papillomavirus (HPV), various cancers, and infectious pathogens. The company's proprietary DNA medicines platform incorporates precisely engineered SynCon technology, which identifies and optimizes the DNA sequence of target antigens, alongside CELLECTRA smart devices designed for efficient delivery of these DNA plasmids.